An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa
Clinical trial NCT05856266 · TERMINATED
Trial details
- NCT number
- NCT05856266
- Sponsor
- Swedish Orphan Biovitrum
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2023-12-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.